983 resultados para Eficácia pessoal
Resumo:
Avaliou-se a eficácia da dose de 0,10 ou de 0,25mg de gonadorelina nas taxas de ovulação e de sincronização no protocolo Ovsynch e de 150mcg de D-cloprostenol ou 0,530mg de cloprostenol sódico na regressão do corpo lúteo (CL) de sete dias e de todos os CL. Foram utilizadas 136 vacas lactantes da raça Holandesa, com média de produção de leite de 23,75,8kg/dia, com 138,4±72,0 dias em lactação. As vacas foram distribuídas aleatoriamente em quatro grupos, de acordo com a dose de gonadorelina e o tipo da prostaglandina. As taxas de ovulação e de sincronização foram de 52,9% e 80,9% para 0,10mg de gonadorelina e de 57,4% e 80,9% para 0,25mg de gonadorelina, respectivamente. A taxa de regressão do CL de sete dias foi de 97,1% para o D-cloprostenol e de 97,5% para o cloprostenol sódico. A taxa de prenhez não foi influenciada pelos tratamentos, mas foi influenciada pela taxa de ovulação à primeira aplicação de gonadorelina, 16,0% vs. 6,6% para as vacas que ovularam e não ovularam, respectivamente. Conclui-se que 0,10mg de gonadorelina foi eficiente e ambas prostaglandinas podem ser usadas em protocolos de sincronização da ovulação.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
OBJETIVO: Compreender os aspectos da dimensão pessoal do processo de trabalho para enfermeiras que atuam em Unidades de Terapia Intensiva (UTI) de um hospital universitário do interior do Estado de São Paulo. MÉTODOS: Estudo de abordagem qualitativa utilizando o método fenomenológico. Foram entrevistadas 12 enfermeiras que trabalhavam nas UTI de adulto, pediátrica e coronariana dessa instituição hospitalar e para análise dos relatos, utilizou-se o referencial da estrutura do fenômeno situado. RESULTADOS: A análise dos relatos permitiu identificar a categoria: dimensão pessoal do trabalho na UTI, com os temas - trabalho gratificante, trabalho desgastante e (des) valorização do trabalho. CONCLUSÃO: Os resultados do estudo revelam que as enfermeiras das UTI selecionadas identificam-se com o trabalho, porém vivenciam situações desmotivadoras decorrentes da elevada carga de trabalho, que dificulta o desenvolvimento do processo de trabalho e compromete a qualidade do cuidado.
Resumo:
TEMA: eficácia da reabilitação em disfagia orofaríngea. A atuação fonoaudiológica com disfagia orofaríngea em nosso País alcançou proporções significativas e merece neste momento atenção para que esta atuação esteja baseada em evidências científicas. As técnicas terapêuticas e a eficácia da reabilitação em disfagia orofaríngea têm sido estudadas desde a década de 70, alcançando seu ápice na década de 80 e 90. Poucos estudos têm relatado a eficácia da reabilitação em disfagia orofaríngea, sendo mais freqüente aqueles que têm se preocupado em provar os efeitos da técnica terapêutica na dinâmica da deglutição. No Brasil, as pesquisas em disfagia orofaríngea têm valorizado os procedimentos de avaliação, sendo poucos os trabalhos que tratam da reabilitação. OBJETIVO: apresentar uma análise crítica sobre a eficácia da reabilitação em disfagia orofaríngea. CONCLUSÃO: este artigo de revisão aponta que estudos não randomizados têm comprometido os resultados, uma vez que a casuística das pesquisas têm utilizado amostras muito heterogêneas, que incluem disfagias orofaríngeas mecânicas e neurogênicas ocasionadas por distintas etiologias. Além disto, os programas terapêuticos empregados são pouco descritivos comprometendo a reprodução por parte de outros pesquisadores. Tais achados sugerem a necessidade de estudos mais randomizados, talvez inicialmente por meio de estudos de casos que possam excluir as variáveis do controle da eficácia terapêutica. Outra sugestão seria empregar, assim como as pesquisas atuais têm proposto, escalas que possam medir o impacto do treinamento de deglutição nas condições nutricionais e pulmonares do indivíduo disfágico. Uma importante área da pesquisa, relacionada ao controle da eficiência e eficácia terapêutica, está nos estudos que objetivam estabelecer o grau de redução de custos hospitalares e em empresas de home care, mediante a atuação do fonoaudiólogo com a disfagia orofaríngea.
Resumo:
TEMA: programa de remediação auditivo-visual computadorizado em escolares com dislexia do desenvolvimento. OBJETIVOS: verificar a eficácia de um programa de remediação auditivo-visual computadorizado em escolares com dislexia do desenvolvimento. Dentre os objetivos específicos, o estudo teve como finalidade comparar o desempenho cognitivo-lingüístico de escolares com dislexia do desenvolvimento com escolares bons leitores; comparar os achados dos procedimentos de avaliação de pré e pós testagem em escolares com dislexia submetidos e não submetidos ao programa; e, por fim, comparar os achados do programa de remediação em escolares com dislexia e escolares bons leitores submetidos ao programa de remediação. MÉTODO: participaram deste estudo 20 escolares, sendo o grupo I (GI) subdivido em: GIe, composto de cinco escolares com dislexia do desenvolvimento submetidos ao programa, e GIc, composto de cinco escolares com dislexia do desenvolvimento não submetidos ao programa. O grupo II (GII) foi subdividido em GIIe, composto de cinco escolares bons leitores submetidos à remediação, e GIIc, composto de cinco escolares bons leitores não submetidos à remediação. Foi realizado o programa de remediação auditivo-visual computadorizado Play-on. RESULTADOS: os resultados deste estudo revelaram que o GI apresentou desempenho inferior em habilidade de processamento auditivo e de consciência fonológica em comparação com o GII em situação de pré-testagem. Entretanto, o GIe apresentou desempenho semelhante ao GII em situação de pós-testagem, evidenciando a eficácia da remediação auditivo-visual em escolares com dislexia do desenvolvimento. CONCLUSÃO: o estudo evidenciou a eficácia do programa de remediação auditivo-visual em escolares com dislexia do desenvolvimento.
Resumo:
This experiment aimed to evaluate the selectivity and efficacy of ACCase-inhibiting herbicides in castor bean crop, at Paraguacu Paulista, São Paulo, during the 2002/03 agricultural season. The experimental design used was randomized complete blocks, with eleven treatments and four replicates, constituted by the following herbicides and adjuvants: fluazifop-p-butyl 313 g ha(-1)) + Agral (TM) 0.2% v/v); sethoxydim 322 g ha(-1)) + Assist (TM) 0.5% v/v); haloxyfop-methyl 120 g ha(-1)) + Assist (TM) 0.5% v/v); clethodim+ fenoxaprop-p-ethyl 75 g ha(-1)) + Assist (TM) 0.5% v/v); quizalofop-pethyl 125 g ha(-1)) + Assist (TM) 0.5% v/v); clethodim 156 g ha(-1)) + Assist (TM) 0.5% v/v); propaquizafop 175 g ha(-1)) + Assist (TM) 0.5% v/v); tepraloxydim 400 g ha(-1)) + Dash (TM) 0.5% v/v); butroxydim 100 g ha(-1)) + Dash (TM) 0.5% v/v); isoxaflutole 60 g ha(-1)) and weed-free check. At the moment of application, castor bean plants presented 4 to 6 leaves and Cenchrus echinatus, 1 to 5 tillers. AL Guarany 2002 cultivar presented high selectivity to ACCase-inhibiting herbicides, without visible symptoms of phytotoxicity in 14 DAA days after application), except for tepraloxydim, whose symptoms persisted until 21 DAA, and isoxaflutole HPPD inhibiting), which showed injuries in older leaves and significant yield reduction. C. echinatus infestation was efficiently controlled by ACCase-inhibiting herbicides between 14 and 21 DAA (>= 95.0%).
Resumo:
Objective: to assess the efficacy and safety of the use of nebulized L-epinephrine associated with dexamethasone in post-intubation laryngitis. Method: we carried out a prospective, randomized, double-blind, placebo controlled study with two cohorts of patients with postintubation laryngitis graded 3 to 6 by Downes and Raphaely score and during two years. Our population was divided into two groups: A and B; both groups received intravenous dexamethasone and nebulized saline with (group B) and without (group A) L-epinephrine. The efficacy was assessed by Downes and Raphaely's score. The side effects of epinephrine were evaluated according to occurrence of arrhythmia, to increased blood pressure, and to average heart rate of group B in comparison to group A. Results: twenty-two patients were included in group A (average score = 4.8) and 19 in group B (average score = 5.2). During treatment, 3 patients in group A presented a score of 8 and were reintubated. This group also showed higher clinical scores than group B during the first two hours of the protocol; these results were not statistically significant. No side effects were observed due to epinephrine. The gasometric parameters were adequate in both groups, but better in the control group. Conclusions: we did not observe increased efficacy for the treatment of post-intubation laryngitis when nebulized L-epinephrine was used simultaneously with intravenous dexamethasone. Some indicators, however, did present a favorable trend when combined therapy was used and should be submitted to further evaluation.
Resumo:
Introduction: Hypercholesterolemia is an important risk factor for cardiovascular disease, the first cause of death and third reason for hospital admissions in Brazil. The reduction of serum cholesterol levels reduces morbidity and mortality from cardiovascular disease. The present study evaluated the efficacy and safety of atorvastatin in the treatment of Brazilian patients with primary hypercholesterolemia (types IIA and IIB dyslipidemias). Patients and methods: After a 4-week wash-out period, 152 patients were treated with atorvastatin at the initial dose of 10 mg/day. According to treatment efficacy within the first 8 weeks this dose could be increased to 20 mg/day. Treatment lasted for a total of 16 weeks, and its efficacy was evaluated by the reduction of serum levels of LDL-cholesterol, total cholesterol, HDL-cholesterol, and triglycerides, as well as by the propotion of patients that achieved the target levels recommended by the National Cholesterol Education Program - Adult Treatment Panel II (NCEP ATP II) Results: The analysis of efficacy was conducted in 145 patients. Atorvastatin led to significant reductions in the levels of LDL-cholesterol after 8 and 16 weeks of treatment (P<0.001 for both comparisons). The relative reduction of such levels was 38% (P<0.001 after 8 and 16 weeks). Atorvastatin also led to significant reductions of total cholesterol and triglycerides. At the end of the study, 81% of patients achieved the target LDL-cholesterol levels recommended by NCEP ATP II. Treatment was well tolerated, and was interrupted due to creatine phosphokinase elevation in only one patient. Conclusion: Atorvastatina is efficacious and safe in the treatment of patients with primary hypercholesteromia. © Copyright Moreira Jr. Editora. Todos os direitos reservados.
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
The main goal of this work is to present a supplier's management method based on evaluation of audits performed at suppliers during products development phase. Audits are prioritized according to the impact of supplied parts on the development and its main goals are identification of risks, to propose and perform action plans and to evaluate periodically the supplier's performance to prevent problems. It is proposed that if the audits in the development phase be efficient, the supplied products will have good maturity to entry into service and stable performance. This issue was evaluated in a aeronautic company and the analyzed results in 2006 were considered good.
Resumo:
The aim of this research was to evaluate the efficacy of plant extracts and chemical products for the control of Boophilus microplus. Three commercial products for the control of Boophilus microplus were in vitro evaluated, chemical compounds of cypermethrin + DDVP and organophosphate as recomended by the manufacturer, and also four plant extracts, Azadirachta indica (1%), Cymbopogon densiflorus, Lippia alba and Ipomoea asarifolia at different concentrations. The results showed that the chemical compounds tested had efficacy lower than 95% against the Boophilus microplus samples in the experiment. The extracts of all plants have shown some biological activity in the mortality of ingurgitated females and inhibition of egg crash, however the extract of Azadirachta indica presented efficacy higher than 95% in all tested concentrations, being the best sample tested in this experiment.
Resumo:
Pain is a subjective condition and, thus, difficult to measure. The best tools to assess pain are the pain evaluation questionnaires, which provide either diagnostic, pain evolution or pain intensity information. To provide information which could help differentiate between nociceptive pain and neuropathic pain is one of the most important functions of these questionnaires. The questionnaires can measure pain intensity, quality of life, or sleep quality. Quality of life and sleep are two really important characteristics to assess the pain impact on patients' life. Pain intensity assessing questionnaires combine physical evaluations with questions, providing information either from the patient sensations or clinical assessment of pain manifestations as well as the underlying biological mechanisms (such as hyperalgesia or allodynia). For example, the Pain Detect questionnaire has two parts: the patient form (intuitive, with pictures and easy understandable) and the physician form. Thus, in this questionnaire, subjective information is provided by the patient and the objective one is provided by the physician. Other pain intensity questionnaires are NPSI, DN4, LANSS or StEP. Quality of life questionnaires are versatile (can be used in different pathologies). These questionnaires include functional self-evaluation questions, and other ones associated to physical and mental health. Two of such quality of life questionnaires are SF-36 and NHP. Sleep evaluation questionnaires include quantitative features such as the number of sleep interruptions, sleep latency or sleep duration as well as qualitative characteristics such as rest sensation, mood and dreams. One of the most used sleep evaluation questionnaires is PSQI, which includes patient questions and bed-partner questions, providing information from two points of view. Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.
Resumo:
Aim: This study aimed to evaluate the efficacy of a new topical drug (EF028) in two separate presentations (aerosol and cream) in a comparative way with the already registered medication, Andolba® (benzocaine, benzoxiquina chloride benzeconio, menthol) and the negative control (hygiene), in the analgesic efficacy after episiotomy wound, reducing the requirement for systemic medication. Methods: 60 patients were voluntary post normal vaginal childbirth with episiotomy, were divided into four groups to comparatively assess the action of the product EF028 (cream and aerosol), Andolba® and soap, the efficacy of decreasing painful symptoms from daily use for 2 times a day for seven days. Clinical assessments and subjective pain occurred daily until the third postoperative day and on the 7th postoperative day. Results: The results showed that the drugs promoted a reduction of painful symptoms and there was no statistically significant difference (p <0.05) between presentations of drug EF028 (cream and aerosol) and Andolba® and the three products were significantly higher (p <0.05) to the control. Conclusions: The evaluated drugs EF028 aerosol, EF028 cream and Andolba® had similar efficacy in relieving the painful symptoms of the perineal region in postoperative episiotomy can be considered as indication for postoperative episiotomies. © Copyright Moreira Jr. Editora.